BlackRock Investment Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.52M | Sell |
146,146
-205
| -0.1% | -$2.13K | ﹤0.01% | 2402 |
|
|
2016
Q3 | $1.32M | Buy |
146,351
+2,043
| +1% | +$18.5K | ﹤0.01% | 2470 |
|
|
2016
Q2 | $1.08M | Buy |
144,308
+13,708
| +10% | +$102K | ﹤0.01% | 2559 |
|
|
2016
Q1 | $1.18M | Buy |
130,600
+34,149
| +35% | +$308K | ﹤0.01% | 2371 |
|
|
2015
Q4 | $1.25M | Buy |
96,451
+1,847
| +2% | +$23.9K | ﹤0.01% | 2436 |
|
|
2015
Q3 | $914K | Buy |
94,604
+3,877
| +4% | +$37.5K | ﹤0.01% | 2660 |
|
|
2015
Q2 | $934K | Buy |
90,727
+68,221
| +303% | +$702K | ﹤0.01% | 2808 |
|
|
2015
Q1 | $250K | Sell |
22,506
-506
| -2% | -$5.62K | ﹤0.01% | 3164 |
|
|
2014
Q4 | $268K | Buy |
23,012
+112
| +0.5% | +$1.3K | ﹤0.01% | 3197 |
|
|
2014
Q3 | $507K | Buy |
22,900
+430
| +2% | +$9.52K | ﹤0.01% | 2955 |
|
|
2014
Q2 | $624K | Buy |
+22,470
| New | +$624K | ﹤0.01% | 2908 |
|